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Available online 5 October 2004Abstract—Gram positive (Bacillus cereus, B. subtilis), Gram negative (Pseudomonas aeruginosa, Escherichia coli) bacteria, and Can-
dida albicans as a representative of fungi were used for screening the in vitro antimicrobial activity of diarylamines in the 2,3,5-tri-
methylbenzo[b]thiophene series bearing diﬀerent substituents, synthesized by us using the palladium-catalyzed C–N coupling
methodology. The minimal inhibitory concentration (MIC) and structure–activity relationships (SARs) were evaluated.
 2004 Elsevier Ltd. All rights reserved.The enhance prevalence of infectious diseases is becom-
ing a world wide problem. Additionally, the resistance
problem demands that a renewed eﬀort should be made
to seek antimicrobial agents eﬀective against pathogenic
microorganisms resistant to current treatment.
Benzo[b]thiophenes are important heterocycles as bio-
logical active molecules.1–5 Recently we have been inter-
ested in the palladium-catalyzed aryl amination of
benzo[b]thiophenes either in the benzene or in the thio-
phene ring to obtain the corresponding diarylamines
and in some cases the tetracyclic aromatic compounds
resulting from intramolecular cyclizations.6,7 We have
been able to establish that under the same C–N coupling
conditions [Pd(OAc)2 (3mol%), Cs2CO3 (1.4equiv), and
BINAP (4mol%) in toluene] it was possible to obtain
either primary amines8 or diarylamines7,8 in the benzene
ring of the benzo[b]thiophene moiety.
Herein, we describe the structure–activity relationship of
a novel series of diarylamines as antimicrobial agents.
Diﬀerently substituted diarylamines derivatives of
2,3,5-trimethylbenzo[b]thiophene 1 were obtained by
C–N palladium-catalyzed cross-couplings in good to0960-894X/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
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325405; e-mail: iferreira@ipb.pthigh yields (50%-quantitative yield) using either the bro-
mo compound 2 or the amino derivative 3 as coupling
components.8 The latter was prepared from compound
2 using also a C–N palladium-catalyzed cross-coupling
with benzophenone imine, followed by acidic hydrolysis
in a 60% overall yield (Scheme 1).8
A screening of antibacterial activities using two Gram
negative (Escherichia coli and Pseudomonas aeruginosa)
and two Gram positive bacteria (Bacillus subtilis and
B. cereus) and antifungal using Candida albicans was
performed for the diarylamines 4–8 and for their
benzo[b]thiophene precursors 1–3, to determine the
importance of the diarylamine skeleton in this series.
The minimal inhibitory concentration (MIC in lg/mL)
was determined (Table 1) using an adaptation of agar
streak dilution method based on radial diﬀusion.9,10 Sus-
pensions of the microorganism were prepared to contain
approximately 108cfu/mL and the plates were inocu-
lated. A stock solution of the synthesized compound
(1000lg/mL) in DMSO was prepared and graded dilu-
tions of the tested compounds were incorporated in a
cavity (depth 3mm, diameter 4mm) made in the center
of the petridish (nutrient agar for antibacterial activity
and sabouraud dextrose agar medium for antifungal
activity). The plates were incubated at 37 C (bacteria)
or 30 C (fungi) for 24h in duplicate. In the same condi-
tions diﬀerent concentrated solutions of Ampicillin,
Chloramphenicol (antibacterial), and Cyclohexamide
Table 1. Antimicrobial activity of the synthesized compounds
Compounds Microorganism MIC (lg/mL)
(zone of inhibition)
(mm)
1 B. cereus (CECT 148) Not active
B. subtilis (CECT 498) Not active
E. coli (CECT 101) Not active
P. aeruginosa (CECT 108) Not active
C. albicans (CECT 1394) Not active
2 B. cereus 1000 (12)
B. subtilis 500 (18)
E. coli Not active
P. aeruginosa Not active
C. albicans Not active
3 B. cereus 500 (10)
B. subtilis 500 (17)
E. coli Not active
P. aeruginosa Not active
C. albicans 1000 (13)
4 B. cereus 200 (18)
B. subtilis 200 (8)
E. coli 200 (4)
P. aeruginosa 200 (16)
5 B. cereus 100 (4)
B. subtilis 50 (19)
E. coli 1000 (4)
P. aeruginosa 1000 (8)
C. albicans 12.5 (6)
6 B. cereus 200 (24)
B. subtilis 200 (10)
E. coli Not active
P. aeruginosa 1000 (10)
C. albicans 25 (8)
7 B. cereus 200 (12)
B. subtilis 200 (10)
E. coli Not active
P. aeruginosa Not active
8 B. cereus 200 (9)


















4, R1 = R2 = H, 17 h, 50%
5, R1 = H, R2 = OMe, 21h, 60%
6, R1 = R2 = OMe, 17 h, 70%
7, R3= F, R4= H, 20 h, 90%










Scheme 1. Synthesis of diarylamines and their precursors in the 2,3,5-trimethylbenzo[b]thiophene series.8 Reagents and conditions: (i) Pd(OAc)2
(3mol%), Cs2CO3 (1.4equiv), BINAP (4mol%), dry toluene, 100C, Ar; (ii) HCl 2M/THF.
Table 1 (continued)
Compounds Microorganism MIC (lg/mL)
(zone of inhibition)
(mm)
E. coli Not active
P. aeruginosa Not active
Ampicillin B. cereus 3.13 (13)
B. subtilis 12.5 (10)
E. coli 6.25 (15)
P. aeruginosa 6.25 (12)
Chloramphenicol B. cereus 3.13 (8)
Cyclohexamide C. albicans 12.5 (5)
CECT—Spanish type culture collection of Valencia University.
5832 I. C. F. R. Ferreira et al. / Bioorg. Med. Chem. Lett. 14 (2004) 5831–5833(antifungal) in DMSO were used as standards. The MIC
was considered to be the lowest concentration of the
tested compound, which inhibits growth of bacteria or
fungi on the plate. The diameters of the inhibition zones
corresponding to the MICs are presented in Table 1.
Positive control using only inoculation and negative
control using only DMSO in the cavity were carried
out. From analysis of Table 1 we can conclude that
2,3,5-trimethylbenzo[b]thiophene 1 is not eﬀective
against none of the microorganisms tested. Insertion
of a bromine atom in the 6-position (compound 2)
shows activity only for Gram positive bacteria but with
high MICs. The substitution of the halogen atom by
an amino group (compound 3) lowers the MIC for
B. cereus and turns it active against C. albicans but still
with high MICs. Diarylamine 4, without substituents in
the phenyl ring, shows activity either against Gram
negative or Gram positive bacteria (MIC 200lg/mL).
The introduction of a OMe group in the para position
(compound 5) lowers the MIC to 100lg/mL for
B. cereus and to 50lg/mL for B. subtilis but increases
it to 1000lg/mL for Gram negative bacteria. The intro-
duction of an additional OMe group (compound
6) makes the compound inactive against E. coli.
I. C. F. R. Ferreira et al. / Bioorg. Med. Chem. Lett. 14 (2004) 5831–5833 5833Compounds with a F atom in the phenyl ring (7 and 8)
show selectivity against Gram positive bacteria. The
presence of the F atom in the ortho position (8) instead
of in the para position (7) lowers the MIC for B. subtilis
from 200 to 50lg/mL. Although the MICs were higher
than the values obtained for ampicillin it is the ﬁrst time
that this type of compounds was submitted to antibacte-
rial studies. Diarylamines 5 and 6 were also submitted to
antifungi preliminary studies using Candida albicans and
the MIC obtained for compound 5 is comparable to the
obtained for cyclohexamide (antifungal).
In conclusion, a new diarylamine series as antimicrobial
agents based on the 2,3,5-trimethylbenzo[b]thiophene
moiety has been developed. The diarylamine skeleton
and the diﬀerent substituents (H, 1 OMe, 2 OMe, or F)
proved to be important for activity, changing selectivi-
ties and MICs, when compared with the functionalized
(Br and NH2) benzo[b]thiophene precursors.Acknowledgements
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